1-20644665-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_032409.3(PINK1):​c.952A>T​(p.Met318Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000737 in 1,614,172 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00086 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00072 ( 1 hom. )

Consequence

PINK1
NM_032409.3 missense

Scores

5
7
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:12

Conservation

PhyloP100: 8.04
Variant links:
Genes affected
PINK1 (HGNC:14581): (PTEN induced kinase 1) This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07187414).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PINK1NM_032409.3 linkuse as main transcriptc.952A>T p.Met318Leu missense_variant 4/8 ENST00000321556.5 NP_115785.1 Q9BXM7-1
PINK1-ASNR_046507.1 linkuse as main transcriptn.3981+920T>A intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PINK1ENST00000321556.5 linkuse as main transcriptc.952A>T p.Met318Leu missense_variant 4/81 NM_032409.3 ENSP00000364204.3 Q9BXM7-1
PINK1ENST00000492302.1 linkuse as main transcriptn.2040A>T non_coding_transcript_exon_variant 2/52
PINK1-ASENST00000451424.1 linkuse as main transcriptn.3981+920T>A intron_variant 2

Frequencies

GnomAD3 genomes
AF:
0.000861
AC:
131
AN:
152222
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00226
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00128
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000900
AC:
226
AN:
251094
Hom.:
1
AF XY:
0.000847
AC XY:
115
AN XY:
135776
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.00248
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00139
Gnomad NFE exome
AF:
0.00135
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000724
AC:
1058
AN:
1461832
Hom.:
1
Cov.:
31
AF XY:
0.000688
AC XY:
500
AN XY:
727224
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000246
Gnomad4 ASJ exome
AF:
0.00253
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00150
Gnomad4 NFE exome
AF:
0.000769
Gnomad4 OTH exome
AF:
0.000679
GnomAD4 genome
AF:
0.000860
AC:
131
AN:
152340
Hom.:
0
Cov.:
33
AF XY:
0.000872
AC XY:
65
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00226
Gnomad4 NFE
AF:
0.00128
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00108
Hom.:
0
Bravo
AF:
0.000529
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.00102
AC:
124
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.000533

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:5
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 17, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024PINK1: PM2 -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMay 26, 2023In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16755580, 22118943, 15970950, 22644621, 18330912, 19351622, 16547921, 22243833, 27094865, 15596610, 21412950, 34426522, 27393345, 24660942, 30665447, 33921279, 35954270) -
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicOct 04, 2023BS1 -
Autosomal recessive early-onset Parkinson disease 6 Uncertain:5
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 26, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Uncertain significance, criteria provided, single submitterclinical testingCentogene AG - the Rare Disease CompanyAug 27, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 25, 2022This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 318 of the PINK1 protein (p.Met318Leu). This variant is present in population databases (rs139226733, gnomAD 0.3%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with in the heterozygous state in several individuals affected with late onset Parkinson's disease (PMID: 15596610, 16755580, 19351622, 22243833, 24660942, 27094865). ClinVar contains an entry for this variant (Variation ID: 447942). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PINK1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityMar 31, 2022- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 03, 2017- -
PINK1-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 30, 2024The PINK1 c.952A>T variant is predicted to result in the amino acid substitution p.Met318Leu. This variant has been reported in the heterozygous state in multiple individuals with both late- and early-onset Parkinson's disease (Rogaeva et al. 2004. PubMed ID: 15596610; Djarmati et al. 2006. PubMed ID: 16755580; Brooks et al. 2009. PubMed ID: 19351622; Pihlstrøm et al. 2014. PubMed ID: 24660942; Bandrés-Ciga et al. 2016. PubMed ID: 27393345; Kuzkina et al. 2022. PubMed ID: 37248217). In vitro functional studies have shown that this variant leads to a loss of PINK1 phosphorylation activity (Broadway et al. 2022. PubMed ID: 35954270). This variant is reported in 0.25% of alleles in individuals of Ashkenazi Jewish descent in gnomAD, including one homozygote. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Uncertain
0.078
D
BayesDel_noAF
Pathogenic
0.31
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.34
T
Eigen
Uncertain
0.26
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.072
T
MetaSVM
Benign
-0.48
T
MutationAssessor
Benign
1.6
L
PrimateAI
Pathogenic
0.79
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.60
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.015
D
Polyphen
0.089
B
Vest4
0.77
MutPred
0.88
Gain of methylation at K319 (P = 0.0356);
MVP
0.88
MPC
0.20
ClinPred
0.077
T
GERP RS
6.1
Varity_R
0.67
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139226733; hg19: chr1-20971158; API